This study proposed that dyslipidemia may serve as the underlying mechanism for AF-SSNHL pathogenesis, and the aberrant metabolism of SLs and GPL-plasmalogens were closely associated with prognosis. The gene discussed is IL31RA; the disease is metabolic syndrome.